Sign In
Buy SAN
$12.47
+0.310 (+2.55%)
At Close: Jun 04, 2026
Press Release: FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection
09:00pm, Thursday, 23'rd Feb 2023 GlobeNewswire Inc.
FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection
La FDA approuve ALTUVIIIO™ une fois par semaine – une nouvelle classe de facteur VIII de remplacement pour le traitement de l’hémophilie A, qui confère une protection significative contre les
Is Banco Santander (SAN) a Great Value Stock Right Now?
02:40pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Banco Santander (SAN) a Great Value Stock Right Now?
11:18am, Tuesday, 21'st Feb 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Abrdn mulls private equity disposal with Santander in frame - report
11:06am, Friday, 17'th Feb 2023
Abrdn is said to mulling an approach from Santander to buy the fund manager's private equity arm for around £250mln. Santander is one of a number of groups that are interested, according to Sky News,
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Janvier 2023
06:01pm, Wednesday, 15'th Feb 2023 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Sanofi: Information concerning the total number of voting rights and shares – January 2023
06:01pm, Wednesday, 15'th Feb 2023 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Santander: A Bank With Still-Existing Upside
03:52pm, Wednesday, 15'th Feb 2023
Many of the financial companies I've been positive about for the past few years have gone firmly into overvalued territory. This includes European banks. One of the exceptions to this pattern is Santa
Press Release: Sanofi announces change in R&D leadership
07:30am, Monday, 13'th Feb 2023 GlobeNewswire Inc.
Communiqué de presse : Sanofi annonce un changement à la tête de sa R&D
07:30am, Monday, 13'th Feb 2023 GlobeNewswire Inc.Builders will scramble to catch up to demand for years, says Santander's Stephen Stanley
02:01pm, Friday, 10'th Feb 2023
UBS's John Lovallo and Santander's Stephen Stanley join 'The Exchange' to discuss the state of housing as more affluent Americans rent.
S&P 500 May Be Set for Strong Performance as Technicals Align in 2023
01:35pm, Monday, 06'th Feb 2023 Investing.com
Should Value Investors Buy Banco Santander (SAN) Stock?
02:40pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Banco Santander (SAN) Stock?
11:17am, Friday, 03'rd Feb 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Sanofi profit narrowly beats forecasts, sees stronger earnings growth in 2023
07:00am, Friday, 03'rd Feb 2023 MarketWatch
The French pharma majorFR:SAN SNY reported net profit of 1.46 billion euros ($1.59 billion) for the quarter, on sales that grew to EUR10.73 billion from EUR9.99 billion in the previous year.
